PT2722046T - CRYSTALLINE FORM 1 OF 2 - ((R) -2-METHYLPYRROLIDINE-2-YL) -1HBENZIMIDAZOLE-4-CARBOXAMIDE - Google Patents

CRYSTALLINE FORM 1 OF 2 - ((R) -2-METHYLPYRROLIDINE-2-YL) -1HBENZIMIDAZOLE-4-CARBOXAMIDE

Info

Publication number: PT2722046T
Authority: PT; Portugal
Prior art keywords: methylpyrrolidine; carboxamide; crystalline form; crystalline
Prior art date: 2007-10-12

Application number

PT141510891T

Other languages

Portuguese (pt)

Inventor

Kolaczkowski Lawrence

Original Assignee

Abbvie Ireland Unlimited Co

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2007-10-12

Filing date

2008-10-10

Publication date

2017-03-15

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40210712&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PT2722046(T) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2008-10-10 Application filed by Abbvie Ireland Unlimited Co filed Critical Abbvie Ireland Unlimited Co

2017-03-15 Publication of PT2722046T publication Critical patent/PT2722046T/en

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs

Landscapes

Chemical & Material Sciences (AREA)
Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Veterinary Medicine (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Epidemiology (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

PT141510891T 2007-10-12 2008-10-10 CRYSTALLINE FORM 1 OF 2 - ((R) -2-METHYLPYRROLIDINE-2-YL) -1HBENZIMIDAZOLE-4-CARBOXAMIDE PT2722046T (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US97964307P	2007-10-12	2007-10-12

Publications (1)

Publication Number	Publication Date
PT2722046T true PT2722046T (en)	2017-03-15

Family

ID=40210712

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PT141510891T PT2722046T (en)	2007-10-12	2008-10-10	CRYSTALLINE FORM 1 OF 2 - ((R) -2-METHYLPYRROLIDINE-2-YL) -1HBENZIMIDAZOLE-4-CARBOXAMIDE

Country Status (28)

Country	Link
US (4)	US8372987B2 (en)
EP (2)	EP2722046B1 (en)
JP (4)	JP2011500589A (en)
KR (2)	KR20100090769A (en)
CN (2)	CN101821270A (en)
AU (1)	AU2008310781B2 (en)
BR (1)	BRPI0816221A8 (en)
CA (2)	CA2696424C (en)
CO (1)	CO6280493A2 (en)
CR (1)	CR11368A (en)
DK (1)	DK2722046T3 (en)
DO (1)	DOP2010000099A (en)
EC (1)	ECSP10010150A (en)
ES (1)	ES2620299T3 (en)
GT (1)	GT201000080A (en)
MX (1)	MX350019B (en)
MY (1)	MY156691A (en)
NZ (1)	NZ583209A (en)
PA (1)	PA8798401A1 (en)
PH (1)	PH12012501636A1 (en)
PL (1)	PL2722046T3 (en)
PT (1)	PT2722046T (en)
RU (2)	RU2476434C2 (en)
SG (1)	SG185297A1 (en)
TW (1)	TWI422588B (en)
UA (2)	UA113277C2 (en)
WO (1)	WO2009049111A1 (en)
ZA (1)	ZA201002090B (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP2722046B1 (en)	2007-10-12	2016-12-21	AbbVie Ireland Unlimited Company	2-((R)-2-methylpyrrolidin-2-yl)-1H-benzimidazole-4-carboxamide crystalline form 1
MX2010003771A (en)	2007-10-12	2010-04-21	Abbott Lab	2-((r)-2-methylpyrrolidin-2-yl)-1h-benzimidazole-4-carboxamide crystalline form 2.
TW201702218A (en)	2014-12-12	2017-01-16	美國杰克森實驗室	Compositions and methods relating to the treatment of cancer, autoimmune disease, and neurodegenerative disease
CN105130961B (en) *	2015-08-06	2018-02-16	苏州晶云药物科技有限公司	ABT 888 crystal formation B and its preparation method and application
CN106995436A (en) *	2016-01-25	2017-08-01	重庆医药工业研究院有限责任公司	A kind of Wei Lipani crystal formations A and preparation method thereof
US20190092756A1 (en) *	2016-03-09	2019-03-28	Crystal Pharmatech Co., Ltd.	Crystalline form a of 2-[(2r)-2-methyl-2-pyrrolidyl]-1h-benzimidazole-7-carboxamide dihydrochloride and preparation method thereof
EP3275434B1 (en)	2016-07-27	2020-08-26	Sandoz Ag	An extended release oral dosage form

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU2930501A (en) *	2000-01-07	2001-07-24	Transform Pharmaceuticals, Inc.	High-throughput formation, identification, and analysis of diverse solid-forms
EP1298125A1 (en) *	2001-09-26	2003-04-02	Aventis Pharma S.A.	Substituted benzimidazole compounds and their use for the treatment of cancer
TWI375673B (en) *	2005-04-11	2012-11-01	Abbott Lab	1h-benzimidazole-4-carboxamides substituted with a quaternary carbon at the 2-position are potent parp inhibitors
EP2722046B1 (en)	2007-10-12	2016-12-21	AbbVie Ireland Unlimited Company	2-((R)-2-methylpyrrolidin-2-yl)-1H-benzimidazole-4-carboxamide crystalline form 1
MX2010003771A (en) *	2007-10-12	2010-04-21	Abbott Lab	2-((r)-2-methylpyrrolidin-2-yl)-1h-benzimidazole-4-carboxamide crystalline form 2.

2008
- 2008-10-10 EP EP14151089.1A patent/EP2722046B1/en active Active
- 2008-10-10 PT PT141510891T patent/PT2722046T/en unknown
- 2008-10-10 DK DK14151089.1T patent/DK2722046T3/en active
- 2008-10-10 PL PL14151089T patent/PL2722046T3/en unknown
- 2008-10-10 KR KR1020107010181A patent/KR20100090769A/en not_active Ceased
- 2008-10-10 EP EP08838001A patent/EP2212327A1/en not_active Ceased
- 2008-10-10 SG SG2012075909A patent/SG185297A1/en unknown
- 2008-10-10 WO PCT/US2008/079441 patent/WO2009049111A1/en not_active Ceased
- 2008-10-10 UA UAA201300752A patent/UA113277C2/en unknown
- 2008-10-10 RU RU2010116397/04A patent/RU2476434C2/en not_active IP Right Cessation
- 2008-10-10 MY MYPI2010001318A patent/MY156691A/en unknown
- 2008-10-10 KR KR1020167008506A patent/KR20160039312A/en not_active Withdrawn
- 2008-10-10 MX MX2010003772A patent/MX350019B/en active IP Right Grant
- 2008-10-10 CN CN200880111619A patent/CN101821270A/en active Pending
- 2008-10-10 PA PA20088798401A patent/PA8798401A1/en unknown
- 2008-10-10 BR BRPI0816221A patent/BRPI0816221A8/en not_active IP Right Cessation
- 2008-10-10 ES ES14151089.1T patent/ES2620299T3/en active Active
- 2008-10-10 CA CA2696424A patent/CA2696424C/en active Active
- 2008-10-10 US US12/248,972 patent/US8372987B2/en not_active Expired - Fee Related
- 2008-10-10 AU AU2008310781A patent/AU2008310781B2/en not_active Ceased
- 2008-10-10 CA CA3006332A patent/CA3006332A1/en not_active Abandoned
- 2008-10-10 PH PH1/2012/501636A patent/PH12012501636A1/en unknown
- 2008-10-10 NZ NZ583209A patent/NZ583209A/en not_active IP Right Cessation
- 2008-10-10 JP JP2010529063A patent/JP2011500589A/en active Pending
- 2008-10-10 CN CN201510450981.4A patent/CN105367554A/en active Pending
- 2008-10-10 UA UAA201005713A patent/UA101961C2/en unknown
- 2008-10-13 TW TW097139239A patent/TWI422588B/en not_active IP Right Cessation
2010
- 2010-03-24 ZA ZA2010/02090A patent/ZA201002090B/en unknown
- 2010-04-08 DO DO2010000099A patent/DOP2010000099A/en unknown
- 2010-04-09 GT GT201000080A patent/GT201000080A/en unknown
- 2010-04-14 CR CR11368A patent/CR11368A/en unknown
- 2010-04-27 CO CO10049261A patent/CO6280493A2/en not_active Application Discontinuation
- 2010-05-03 EC EC2010010150A patent/ECSP10010150A/en unknown
2012
- 2012-11-08 RU RU2012147692/04A patent/RU2012147692A/en not_active Application Discontinuation
2013
- 2013-01-07 US US13/735,190 patent/US20130123317A1/en not_active Abandoned
- 2013-09-27 US US14/039,479 patent/US8835647B2/en active Active
2014
- 2014-07-10 JP JP2014142248A patent/JP2014237659A/en active Pending
- 2014-08-12 US US14/457,866 patent/US9580410B2/en not_active Expired - Fee Related
2016
- 2016-11-11 JP JP2016220220A patent/JP2017071618A/en active Pending
2018
- 2018-09-07 JP JP2018167564A patent/JP2019001811A/en active Pending

Also Published As

Publication number	Publication date
CN101821270A (en)	2010-09-01
PA8798401A1 (en)	2009-05-15
CO6280493A2 (en)	2011-05-20
DOP2010000099A (en)	2017-04-30
SG185297A1 (en)	2012-11-29
TWI422588B (en)	2014-01-11
BRPI0816221A8 (en)	2015-09-22
EP2722046A1 (en)	2014-04-23
CA2696424A1 (en)	2009-04-16
KR20160039312A (en)	2016-04-08
BRPI0816221A2 (en)	2015-06-16
MX350019B (en)	2016-12-09
RU2012147692A (en)	2014-05-20
KR20100090769A (en)	2010-08-17
PH12012501636A1 (en)	2015-07-10
US20150148392A1 (en)	2015-05-28
PL2722046T3 (en)	2017-06-30
EP2212327A1 (en)	2010-08-04
NZ583209A (en)	2012-06-29
CR11368A (en)	2010-10-25
ZA201002090B (en)	2011-11-30
CN105367554A (en)	2016-03-02
JP2019001811A (en)	2019-01-10
RU2010116397A (en)	2011-11-20
UA113277C2 (en)	2017-01-10
AU2008310781A1 (en)	2009-04-16
JP2011500589A (en)	2011-01-06
JP2014237659A (en)	2014-12-18
MY156691A (en)	2016-03-15
UA101961C2 (en)	2013-05-27
AU2008310781B2 (en)	2013-03-28
DK2722046T3 (en)	2017-03-20
US8372987B2 (en)	2013-02-12
WO2009049111A1 (en)	2009-04-16
ES2620299T3 (en)	2017-06-28
MX2010003772A (en)	2010-04-21
CA2696424C (en)	2018-07-10
US20140024838A1 (en)	2014-01-23
CA3006332A1 (en)	2009-04-16
US9580410B2 (en)	2017-02-28
GT201000080A (en)	2012-04-03
US8835647B2 (en)	2014-09-16
RU2476434C2 (en)	2013-02-27
TW200932747A (en)	2009-08-01
EP2722046B1 (en)	2016-12-21
US20090099245A1 (en)	2009-04-16
US20130123317A1 (en)	2013-05-16
ECSP10010150A (en)	2010-06-29
JP2017071618A (en)	2017-04-13

Publication	Publication Date	Title
LTPA2020501I1 (en)	2020-02-10	Substituted enaminocarbonyl compounds
BRPI0922904A2 (en)	2018-05-29	"compounds"
BRPI0915714A2 (en)	2015-10-27	crystalline form of posaconazole
DK2185567T3 (en)	2011-05-16	Substituted bicyclolactam compounds
BRPI1015540A2 (en)	2019-09-24	'' substituted 1-cyanoethylheterocyclylcarboxamide compound 750 ''
BRPI0813500A2 (en)	2015-01-06	ANTIVIAL COMPOUNDS
BRPI0821086A2 (en)	2014-10-07	INSECTICATED COMPOUNDS
DK2262793T3 (en)	2012-10-15	Crystalline forms of nilotinib-hci
BRPI0815042A2 (en)	2015-02-10	PIRAZOL COMPOUNDS
BRPI0910229A2 (en)	2015-09-01	Spirocytically substituted 4 '; 4'-dioxaspiro tetramates
BRPI0811264A2 (en)	2014-11-04	COMPOUNDS
ATE521238T1 (en)	2011-09-15	CRYSTALLINE MODIFICATIONS OF PYRACLOSTROBINE
ZA201003909B (en)	2011-11-30	Crystalline 2-(4-cyclopropanesulphonyl-phenyl)-n-pyrazin-2-yl-3-(tetrahydopyran-4-yl)-propionamide
BRPI0814801A2 (en)	2017-03-28	crystalline pyridazine compound
BRPI0809996A2 (en)	2014-10-14	COMPOUNDS
BRPI0814424A2 (en)	2015-01-06	HYPEROCYCLE COMPOUNDS
BRPI0815181A2 (en)	2015-03-31	COMPOUNDS
PT2722046T (en)	2017-03-15	CRYSTALLINE FORM 1 OF 2 - ((R) -2-METHYLPYRROLIDINE-2-YL) -1HBENZIMIDAZOLE-4-CARBOXAMIDE
BRPI0911678A2 (en)	2015-10-13	anhydrous crystalline form of orvepitant maleate
EP2156837A4 (en)	2012-12-05	CRYSTALLINE MICROPUFF PARTICLES
EP2258697A4 (en)	2011-08-03	HYDROXYQUINOXALINECARBOXAMIDE DERIVATIVE
BRPI0814613A2 (en)	2015-01-27	COMPOUNDS
LT3825306T (en)	2023-08-10	MORFINAN COMPOUNDS
ITMI20042437A1 (en)	2005-03-21	CRYSTALLINE FORM OF RABEPRAZOLO SODICO
EP2170329A4 (en)	2011-08-10	7-ETHYL-10-HYDROXYCAMPTOTHECIN CRYSTALLINE POLYMORPH